Covid-19: Russian vaccine efficacy is 91.6%, show phase III trial results
2014 ◽
Vol 30
(11)
◽
pp. 1041-1045
◽
Keyword(s):
2002 ◽
Vol 38
(11)
◽
pp. S97
◽
Keyword(s):
2010 ◽
Vol 2010
◽
pp. 114-115
Keyword(s):
Keyword(s):